COMMUNIQUÉS West-GlobeNewswire

Cosmos Health Advances International Patent Application for Its Proprietary Hydrogel Weight Management Platform Across the U.S., Europe, Australia, and Canada
25/06/2026
Building on Its Recent Acquisition of the CCX0722 Intellectual Property, Cosmos Health Owns the Technology Outright and Is Now Pursuing Patent Protection Across Four Major Healthcare Markets Within the $190+ Billion [...]
First Stop Health Enhances Healthy Weight Program amid Growing GLP-1 Employee Demand and Employer Costs
25/06/2026
Program provides employers simple, clinically governed GLP-1 management options regardless of plan coverage CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- First Stop Health, the connected, whole-person virtual care platform [...]
Deux athlètes d’élite du Canada deviennent ambassadeurs du programme de dons mensuels de la Croix-Rouge canadienne
25/06/2026
Alphonso Davies et Leylah Fernandez s’associent à la Croix-Rouge canadienne OTTAWA, 25 juin 2026 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne est heureuse d’annoncer que la grande joueuse de tennis canadienne Leylah [...]
Two of Canada’s top athletes named Canadian Red Cross monthly giving ambassadors
25/06/2026
Alphonso Davies and Leylah Fernandez partnering with the Canadian Red Cross OTTAWA, June 25, 2026 (GLOBE NEWSWIRE) -- The Canadian Red Cross is pleased to announce Canadian men’s national soccer team captain Alphonso [...]
Regenix Labs Announces Educational Guide on NAD+, Cellular Energy, and Healthy Aging
25/06/2026
New online guide explores NAD+, cellular energy production, and healthy aging research Regenix Labs logo. NEWARK, Del., June 25, 2026 (GLOBE NEWSWIRE) -- Regenix Labs LLC announces the availability of its educational [...]
Commure Named “Overall NLP Company of the Year” in 2026 AI Breakthrough Awards
25/06/2026
Recognition highlights Commure’s AI-native platform transforming healthcare operations at scale MOUNTAIN VIEW, Calif., June 25, 2026 (GLOBE NEWSWIRE) -- Commure , a leading healthcare technology company, today announced [...]
Xealth Survey Defines Digital Readiness Gaps Between Healthcare Executives and Physicians
25/06/2026
New market insights identify misaligned operational priorities in digital health and outline a framework for unification SEATTLE, June 25, 2026 (GLOBE NEWSWIRE) -- Xealth , the leader in digital health orchestration and [...]
Valneva annonce l’approbation des résolutions présentées à son Assemblée Générale
25/06/2026
Le Dr Gerd Zettlmeissl est nommé président du conseil d’administration Lyon (France), le 25 juin 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que [...]
Valneva Announces Successful Outcome of its Annual General Meeting
25/06/2026
Dr. Gerd Zettlmeissl is appointed as Chair of the Board of Directors Lyon (France), June 25, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that shareholders approved [...]
Chiesi Group and Arbor Biotechnologies Announce ABO-101 Granted Orphan Drug Designation by European Commission for Primary Hyperoxaluria
25/06/2026
ABO-101 is an investigational gene editing therapy designed to address the underlying disease biology of PH1 by reducing hepatic oxalate production Orphan Drug Designation (ODD) highlights the need for additional [...]
Chiesi Group and Arbor Biotechnologies Announce ABO-101 Granted Orphan Drug Designation by European Commission for Primary Hyperoxaluria
25/06/2026
ABO-101 is an investigational gene editing therapy designed to address the underlying disease biology of PH1 by reducing hepatic oxalate production Orphan Drug Designation (ODD) highlights the need for additional [...]
Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus
25/06/2026
Topline Phase 3 Results from C-FORWARD Expected Around Year-End 2026 More Than 880 HCV Treatment-Naïve Patients Enrolled Across 17 Countries Outside North America C-FORWARD and C-BEYOND Represent the First Global Phase [...]
Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management
25/06/2026
ALAMEDA, Calif., June 25, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, [...]
Glass House Brands Announces Uplist to NYSE
25/06/2026
LONG BEACH, Calif. and TORONTO, June 25, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the “Company”) (CBOE CA: GLAS.A.U) (OTCQX: GLASF) today announced that its subordinate voting shares (the “ [...]
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
25/06/2026
HOUSTON, June 25, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV ) (“Plus” or the “Company”), announced today that it has signed a national agreement [...]
BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT™
25/06/2026
Agreement supports potential commercial readiness for Bria-IMT using Uneedle’s proprietary microneedle technology for intradermal administration Technology is currently used in BriaCell’s pivotal Phase 3 study and is [...]
Lycia Therapeutics Raises $75 Million in Oversubscribed Financing and Strengthens Leadership Team with Appointment of Chief Financial Officer and General Counsel
25/06/2026
Financing co-led by Janus Henderson Investors and Balyasny Asset Management, with participation from Adage Capital Management, HBM Healthcare Investments, OrbiMed and continued support from existing investors Proceeds [...]
Nanox Announces First Quarter 2026 Financial Results and Provides Business Updates
25/06/2026
Management to host conference call and webcast on Thursday, June 25, 2026 at 8:30 AM ET PETACH TIKVA, Israel, June 25, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“ Nanox ” or the “ Company ”), an [...]
TRUE-See Selected to Participate in Microsoft for Start-Ups Azure AI Program to Accelerate Innovation and Growth
25/06/2026
Includes $350,000 in non-dilutive Microsoft Azure AI credits for TRUE-See’s R&D that is incorporating AI to increase the utility and diagnostic accuracy of medical photography TRUE-See’s unique patented technology [...]

Pages